These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8845481)

  • 1. In vitro activity of titanocenedichloride versus cisplatin in four ovarian carcinoma cell lines evaluated by a microtiter plate ATP bioluminescence assay.
    Kurbacher CM; Bruckner HW; Andreotti PE; Kurbacher JA; Sass G; Krebs D
    Anticancer Drugs; 1995 Oct; 6(5):697-704. PubMed ID: 8845481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of titanocenedichloride versus cisplatin and doxorubicin in primary and recurrent epithelial ovarian cancer.
    Kurbacher CM; Mallmann P; Kurbacher JA; Sass G; Andreotti PE; Rahmun A; Hübner H; Krebs D
    Anticancer Res; 1994; 14(5A):1961-5. PubMed ID: 7847834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
    Mistry P; Loh SY; Kelland LR; Harrap KR
    Int J Cancer; 1993 Nov; 55(5):848-56. PubMed ID: 8244583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circumvention of drug resistance in cisplatin-resistant sublines of the human squamous carcinoma cell line HLac 79 in vitro and in vivo.
    Bier H
    Acta Otolaryngol; 1991; 111(4):797-806. PubMed ID: 1950544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.
    Mistry P; Kelland LR; Abel G; Sidhar S; Harrap KR
    Br J Cancer; 1991 Aug; 64(2):215-20. PubMed ID: 1892748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of titanocenedichloride in human renal cell carcinoma compared to conventional antineoplastic agents.
    Kurbacher CM; Nagel W; Mallmann P; Kurbacher JA; Sass G; Hübner H; Andreotti PE; Krebs D
    Anticancer Res; 1994; 14(4A):1529-33. PubMed ID: 7979181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of cisplatin (DDP) cytotoxicity in vivo by DL-buthionine sulfoximine (BSO) in DDP-sensitive and-resistant rat ovarian tumors and its relation to DNA interstrand cross links.
    Chen G; Zeller WJ
    Anticancer Res; 1991; 11(6):2231-7. PubMed ID: 1776864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Potentiation of cisplatin sensitivity of cisplatin-resistant human ovarian cancer cell lines by L-buthionine-S,R-sulfoximine].
    Kudoh K; Kita T; Hirata J; Ishii K; Hiramatsu H; Kikuchi Y; Nagata I
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Jun; 46(6):525-32. PubMed ID: 8040625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of buthionine sulfoximine treatment on cellular glutathione levels and cytotoxicities of cisplatin, carboplatin and radiation in human stomach and ovarian cancer cell lines.
    Lee KS; Kim HK; Moon HS; Hong YS; Kang JH; Kim DJ; Park JG
    Korean J Intern Med; 1992 Jul; 7(2):111-7. PubMed ID: 1306072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming tumor necrosis factor-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-alpha. Role of tumor necrosis factor-alpha mRNA down-regulation in tumor cell sensitization.
    Mizutani Y; Yoshida O
    Cancer; 1994 Feb; 73(3):730-7. PubMed ID: 8299097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.
    Hamilton TC; Winker MA; Louie KG; Batist G; Behrens BC; Tsuruo T; Grotzinger KR; McKoy WM; Young RC; Ozols RF
    Biochem Pharmacol; 1985 Jul; 34(14):2583-6. PubMed ID: 4040369
    [No Abstract]   [Full Text] [Related]  

  • 12. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.
    Parekh H; Simpkins H
    Cancer Chemother Pharmacol; 1996; 37(5):457-62. PubMed ID: 8599869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of antitumor activity of cisplatin on human gastric cancer cells in vitro and in vivo by buthionine sulfoximine.
    Saikawa Y; Kubota T; Kuo TH; Furukawa T; Tanino H; Watanabe M; Ishibiki K; Kitajima M
    Jpn J Cancer Res; 1993 Jul; 84(7):787-93. PubMed ID: 8370654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity of antitumor platinum complexes with L-buthionine-(R,S)-sulfoximine and/or etanidazole in human carcinoma cell lines sensitive and resistant to cisplatin.
    Brooks SE; Korbut TT; Dupuis NP; Holden SA; Teicher BA
    Cancer Chemother Pharmacol; 1995; 36(5):431-8. PubMed ID: 7634385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation by D,L-buthionine-S,R-sulphoximine of etoposide cytotoxicity on human non-small cell lung, ovarian and breast carcinoma cell lines.
    Mans DR; Schuurhuis GJ; Treskes M; Lafleur MV; Retèl J; Pinedo HM; Lankelma J
    Eur J Cancer; 1992; 28A(8-9):1447-52. PubMed ID: 1325177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular glutathione content, in vitro chemoresponse, and the effect of BSO modulation in samples derived from patients with advanced ovarian cancer.
    Lewandowicz GM; Britt P; Elgie AW; Williamson CJ; Coley HM; Hall AG; Sargent JM
    Gynecol Oncol; 2002 May; 85(2):298-304. PubMed ID: 11972391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma.
    Andreotti PE; Cree IA; Kurbacher CM; Hartmann DM; Linder D; Harel G; Gleiberman I; Caruso PA; Ricks SH; Untch M
    Cancer Res; 1995 Nov; 55(22):5276-82. PubMed ID: 7585588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.
    Shellard SA; Hosking LK; Hill BT
    Cancer Res; 1991 Sep; 51(17):4557-64. PubMed ID: 1873800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines.
    Lai GM; Ozols RF; Young RC; Hamilton TC
    J Natl Cancer Inst; 1989 Apr; 81(7):535-9. PubMed ID: 2493524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts.
    Goddard P; Valenti M; Kelland LR
    Anticancer Res; 1994; 14(3A):1065-70. PubMed ID: 8074451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.